IOVA logo

Iovance Biotherapeutics, Inc. (IOVA) CAPEX

annual CAPEX:

$11.07M-$11.22M(-50.34%)
December 31, 2024

Summary

  • As of today (September 15, 2025), IOVA annual capital expenditures is $11.07 million, with the most recent change of -$11.22 million (-50.34%) on December 31, 2024.
  • During the last 3 years, IOVA annual CAPEX has fallen by -$26.50 million (-70.54%).
  • IOVA annual CAPEX is now -76.34% below its all-time high of $46.79 million, reached on December 31, 2020.

Performance

IOVA CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAcash flow metrics

quarterly CAPEX:

$7.46M+$1.25M(+20.13%)
June 30, 2025

Summary

  • As of today (September 15, 2025), IOVA quarterly capital expenditures is $7.46 million, with the most recent change of +$1.25 million (+20.13%) on June 30, 2025.
  • Over the past year, IOVA quarterly CAPEX has increased by +$7.02 million (+1588.01%).
  • IOVA quarterly CAPEX is now -68.03% below its all-time high of $23.34 million, reached on December 31, 2020.

Performance

IOVA quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAcash flow metrics

TTM CAPEX:

$20.13M+$7.02M(+53.54%)
June 30, 2025

Summary

  • As of today (September 15, 2025), IOVA TTM capital expenditures is $20.13 million, with the most recent change of +$7.02 million (+53.54%) on June 30, 2025.
  • Over the past year, IOVA TTM CAPEX has increased by +$8.41 million (+71.76%).
  • IOVA TTM CAPEX is now -67.27% below its all-time high of $61.50 million, reached on June 30, 2021.

Performance

IOVA TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIOVAcash flow metrics

IOVA CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-50.3%+1588.0%+71.8%
3 y3 years-70.5%+63.0%-39.5%
5 y5 years+60.0%+50.0%+96.0%

IOVA CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.5%at low-21.6%+1588.0%-39.5%+93.0%
5 y5-year-76.3%+60.0%-68.0%+1588.0%-67.3%+96.0%
alltimeall time-76.3%>+9999.0%-68.0%>+9999.0%-67.3%>+9999.0%

IOVA CAPEX History

DateAnnualQuarterlyTTM
Jun 2025
-
$7.46M(+20.1%)
$20.13M(+53.5%)
Mar 2025
-
$6.21M(+49.0%)
$13.11M(+18.4%)
Dec 2024
$11.07M(-50.3%)
$4.17M(+82.2%)
$11.07M(+6.1%)
Sep 2024
-
$2.29M(+417.6%)
$10.43M(-11.0%)
Jun 2024
-
$442.00K(-89.4%)
$11.72M(-43.7%)
Mar 2024
-
$4.17M(+18.2%)
$20.80M(-6.7%)
Dec 2023
$22.29M(+9.1%)
$3.53M(-1.3%)
$22.29M(+2.3%)
Sep 2023
-
$3.58M(-62.4%)
$21.78M(+11.2%)
Jun 2023
-
$9.52M(+68.1%)
$19.59M(+33.7%)
Mar 2023
-
$5.66M(+87.4%)
$14.65M(-28.3%)
Dec 2022
$20.43M(-45.6%)
$3.02M(+117.9%)
$20.43M(-18.2%)
Sep 2022
-
$1.39M(-69.7%)
$24.97M(-24.9%)
Jun 2022
-
$4.58M(-60.0%)
$33.27M(-13.2%)
Mar 2022
-
$11.44M(+51.2%)
$38.31M(+2.0%)
Dec 2021
$37.57M(-19.7%)
$7.57M(-21.9%)
$37.57M(-29.6%)
Sep 2021
-
$9.69M(+0.7%)
$53.34M(-13.3%)
Jun 2021
-
$9.62M(-10.2%)
$61.50M(+8.2%)
Mar 2021
-
$10.71M(-54.1%)
$56.86M(+21.5%)
Dec 2020
$46.79M(+576.5%)
$23.34M(+30.8%)
$46.79M(+74.1%)
Sep 2020
-
$17.84M(+258.7%)
$26.88M(+161.7%)
Jun 2020
-
$4.97M(+681.0%)
$10.27M(+52.6%)
Mar 2020
-
$637.00K(-81.4%)
$6.73M(-2.7%)
Dec 2019
$6.92M(+477.4%)
$3.43M(+177.6%)
$6.92M(+82.7%)
Sep 2019
-
$1.23M(-13.9%)
$3.79M(+25.6%)
Jun 2019
-
$1.43M(+73.9%)
$3.02M(+50.7%)
Mar 2019
-
$824.00K(+179.3%)
$2.00M(+66.9%)
Dec 2018
$1.20M(+16.5%)
$295.00K(-36.3%)
$1.20M(+41.8%)
Sep 2018
-
$463.00K(+10.8%)
$845.00K(+31.0%)
Jun 2018
-
$418.00K(+1800.0%)
$645.00K(+156.0%)
Mar 2018
-
$22.00K(-137.9%)
$252.00K(-75.5%)
Dec 2017
$1.03M(-32.4%)
-$58.00K(-122.1%)
$1.03M(-43.7%)
Sep 2017
-
$263.00K(+952.0%)
$1.83M(-20.2%)
Jun 2017
-
$25.00K(-96.9%)
$2.29M(-1.3%)
Mar 2017
-
$798.00K(+7.8%)
$2.32M(+52.3%)
Dec 2016
$1.52M
$740.00K(+2.1%)
$1.52M(+63.2%)
DateAnnualQuarterlyTTM
Sep 2016
-
$725.00K(+1242.6%)
$932.00K(+233.0%)
Jun 2016
-
$54.00K(+2600.0%)
$279.90K(-22.9%)
Mar 2016
-
$2000.00(-98.7%)
$362.90K(-68.3%)
Dec 2015
$1.14M(-28.2%)
$151.00K(+107.1%)
$1.14M(-52.7%)
Sep 2015
-
$72.90K(-46.8%)
$2.42M(-3.5%)
Jun 2015
-
$137.00K(-82.5%)
$2.51M(+5.7%)
Mar 2015
-
$782.10K(-45.2%)
$2.37M(+48.9%)
Dec 2014
$1.59M(>+9900.0%)
$1.43M(+789.6%)
$1.59M(+859.0%)
Sep 2014
-
$160.30K(+6869.6%)
$166.00K(+802.2%)
Jun 2014
-
$2300.00(-32.4%)
$18.40K(+14.3%)
Mar 2014
-
$3400.00(>+9900.0%)
$16.10K(+26.8%)
Dec 2013
$12.70K(>+9900.0%)
$0.00(-100.0%)
$12.70K(0.0%)
Sep 2013
-
$12.70K(>+9900.0%)
$12.70K(>+9900.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2012
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 2012
-
$0.00(0.0%)
$10.70K(-24.6%)
Jun 2012
-
$0.00(0.0%)
$14.20K(-54.3%)
Mar 2012
-
$0.00(-100.0%)
$31.10K(0.0%)
Dec 2011
$31.10K(>+9900.0%)
$10.70K(+205.7%)
$31.10K(+78.7%)
Sep 2011
-
$3500.00(-79.3%)
$17.40K(+25.2%)
Jun 2011
-
$16.90K(>+9900.0%)
$13.90K(-1644.4%)
Mar 2011
-
$0.00(-100.0%)
-$900.00(<-9900.0%)
Dec 2010
$0.00(0.0%)
-$3000.00(<-9900.0%)
$0.00(-100.0%)
Sep 2010
-
$0.00(-100.0%)
$3000.00(0.0%)
Jun 2010
-
$2100.00(+133.3%)
$3000.00(+233.3%)
Mar 2010
-
$900.00(>+9900.0%)
$900.00(>+9900.0%)
Dec 2009
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2009
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2009
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2008
$0.00
$0.00(0.0%)
$0.00(0.0%)
Sep 2008
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2008
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2008
-
$0.00
$0.00

FAQ

  • What is Iovance Biotherapeutics, Inc. annual capital expenditures?
  • What is the all time high annual CAPEX for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. annual CAPEX year-on-year change?
  • What is Iovance Biotherapeutics, Inc. quarterly capital expenditures?
  • What is the all time high quarterly CAPEX for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. quarterly CAPEX year-on-year change?
  • What is Iovance Biotherapeutics, Inc. TTM capital expenditures?
  • What is the all time high TTM CAPEX for Iovance Biotherapeutics, Inc.?
  • What is Iovance Biotherapeutics, Inc. TTM CAPEX year-on-year change?

What is Iovance Biotherapeutics, Inc. annual capital expenditures?

The current annual CAPEX of IOVA is $11.07M

What is the all time high annual CAPEX for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high annual capital expenditures is $46.79M

What is Iovance Biotherapeutics, Inc. annual CAPEX year-on-year change?

Over the past year, IOVA annual capital expenditures has changed by -$11.22M (-50.34%)

What is Iovance Biotherapeutics, Inc. quarterly capital expenditures?

The current quarterly CAPEX of IOVA is $7.46M

What is the all time high quarterly CAPEX for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high quarterly capital expenditures is $23.34M

What is Iovance Biotherapeutics, Inc. quarterly CAPEX year-on-year change?

Over the past year, IOVA quarterly capital expenditures has changed by +$7.02M (+1588.01%)

What is Iovance Biotherapeutics, Inc. TTM capital expenditures?

The current TTM CAPEX of IOVA is $20.13M

What is the all time high TTM CAPEX for Iovance Biotherapeutics, Inc.?

Iovance Biotherapeutics, Inc. all-time high TTM capital expenditures is $61.50M

What is Iovance Biotherapeutics, Inc. TTM CAPEX year-on-year change?

Over the past year, IOVA TTM capital expenditures has changed by +$8.41M (+71.76%)
On this page